Unexpected similarities between raindrops and proteinsMay 26, 2004Raindrops and proteins seem to have a lot in common. This has been shown in a new study by scientists at Ume'å University in Sweden. The principle behind the formation of raindrops is very similar to how proteins fold. This knowledge is vital to our understanding of neurodegenerative diseases like ALS. These findings have been published in the latest issue of the journal Proceedings of the National Academy of Sciences and have caught the attention of the international research community. The study was carried out by the biochemists Mikael Oliveberg and Linda Hedberg at Ume'å University. To form a raindrop, it is not enough for a few water molecules to stick together. About 100 water molecules have to conglomerate at the same time. If there are fewer, the drop cannot begin to grow, but it falls to pieces immediately. Using newly developed theory, Linda Hedberg and Mikael Oliveberg have shown that the inscrutable building blocks of the body, proteins, adopt their proper shape in a similar manner. Unlike water, proteins are made up of long chains, and these chains have to instantly fold to a globular form to keep the normal function of the cell. But just like raindrops, it is not enough if just a few segments of the protein chains start tangling together. All parts have to come together at once, otherwise nothing happens. The scientists see a key principle in this. "Now that we see the similarities between the genesis of raindrops and the folding of proteins we can also analyze protein folding in a clearer light. We have a stringent theory to follow," says Mikael Oliveberg. The complicated way in which proteins fold offers the advantage that no half-developed proteins are formed. If such half-developed proteins nevertheless accumulate, they tend to stick to each other, which in turn can lead the cell to "commit suicide". Such improper folding in the sensitive nerve cells lies behind severe disorders like ALS, mad-cow disease, and Alzheimer's disease. At present these diseases are incurable because the knowledge of the misfolding process is yet fragmental. With the aid of the new theory, these scientists are now working to map what parts of the proteins control the folding and what parts are vulnerable to noxious misfolding. The findings could represent an important step toward a more detailed molecular understanding of how proteins behave in our cells and what happens when things go wrong. As so often in the past, parts of the puzzle turn up when they are least expected: in this case the principle behind the formation of raindrops may be the key to understanding neurodegenerative diseases. "The connection between raindrops and proteins may seem simple, but simple solutions are often the right ones. It also shows how everything fits together in nature. Phenomena recur, but with different faces. If we can understand protein folding with help of this theory, we will also be gaining a greater knowledge of life and why things sometimes go wrong," says Mikael Oliveberg. VetenskapsrÃ¥det (The Swedish Research Council) |
|||||||||||||||||||||
| Related Neurodegenerative Disease Current Events and Neurodegenerative Disease News Articles Novel mouse gene reduces major pathologies associated with Alzheimer's disease A new study reveals that a previously undiscovered mouse gene reduces the two major pathological perturbations commonly associated with Alzheimer's disease (AD). Mouse gene suppresses Alzheimer's plaques and tangles Investigators at Burnham Institute for Medical Research (Burnham) and colleagues have identified a novel mouse gene (Rps23r1) that reduces the accumulation of two toxic proteins that are major players in Alzheimer's disease: amyloid beta and tau. Widely used cholesterol-lowering drug may prevent progression Simvastatin, a commonly used, cholesterol-lowering drug, may prevent Parkinson's disease from progressing further. Neurological researchers at Rush University Medical Center conducted a study examining the use of the FDA-approved medication in mice with Parkinson's disease and found that the drug successfully reverses the biochemical, cellular and anatomical changes caused by the disease. Member of NFL Hall of Fame diagnosed with degenerative brain disease The Center for the Study of Traumatic Encephalopathy (CSTE) at Boston University School of Medicine (BUSM) announced today that a recently deceased member of the NFL Hall of Fame suffered from the degenerative brain disease Chronic Traumatic Encephalopathy (CTE) when he died, becoming the 10th former NFL player diagnosed with the disease. First former college football player diagnosed with CTE The Center for the Study of Traumatic Encephalopathy (CSTE) at Boston University School of Medicine (BUSM) announced today that a deceased former college football player who died at age 42 was already suffering from the degenerative brain disease, Chronic Traumatic Encephalopathy (CTE). Natural compounds, chemotherapeutic drugs may become partners in cancer therapy Research in the Linus Pauling Institute at Oregon State University suggests that some natural food compounds, which previously have been studied for their ability to prevent cancer, may be able to play a more significant role in treating it - working side-by-side with the conventional drugs that are now used in chemotherapy. August 10, 2009 New Class of Compounds Discovered for Potential Alzheimer's Disease Drug, Penn Study Finds A new class of molecules capable of blocking the formation of specific protein clumps that are believed to contribute to the dementia of Alzheimer's disease (AD) patients has been discovered by researchers at the University of Pennsylvania School of Medicine. Caffeine reverses memory impairment in Alzheimer's mice Coffee drinkers may have another reason to pour that extra cup. When aged mice bred to develop symptoms of Alzheimer's disease were given caffeine - the equivalent of five cups of coffee a day - their memory impairment was reversed. Huntington's disease deciphered Researchers at the University of Illinois at Chicago College of Medicine have discovered how the mutated huntingtin gene acts on the nervous system to create the devastation of Huntington's disease. What separates dangerous blood vessel plaques from benign ones Researchers say they have evidence to explain what separates your average blood vessel plaque from those that are at high risk for triggering the development of dangerous-even fatal-blood clots. More Neurodegenerative Disease Current Events and Neurodegenerative Disease News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||